Smith appointed vice president quality and regulatory affairs at AAIPharma
This article was originally published in SRA
AAIPharma Services, a US-based provider of pharmaceutical product development services, has appointed Christopher Smith vice president of quality and regulatory affairs. Mr Smith has more than 30 years’ experience in the pharmaceutical industry. He has worked in regulatory affairs and quality assurance at the US Food and Drug Administration, Abbott Laboratories and Endeavor Pharmaceuticals; most recently, he built the global quality assurance function for AAIPharma Services’ former parent company, AAIPharma Inc.
Mr Smith will lead AAIPharma Services’ efforts to support customers with their regulatory strategy and submission needs as well as head the company’s good manufacturing practice compliance efforts.
AAIPharma Services notes that this executive appointment is its first since partnering in July with private equity firm Water Street Healthcare Partners to separate from AAIPharma and become an independent company.